Skip to content
  • 6,812 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Vendor, Minneapolis, MN

National Institute for Pharmaceutical Technology & Education Inc.

UEI RKVKGV1CJDB8, CAGE 4XQ36

4 awards and $2,151,882 obligated between August 16, 2024 and September 15, 2026, 100% under full and open competition, against 42.0 offers on average where reported.

On USAspending Markdown

Sells to

Awarding agencies by dollars.

Food and Drug Administration$2,151,882

Industries

NAICS on the awards, by dollars.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715$1,517,240
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714$634,642

How it wins

Awards by competition, set-aside and type.

Full and Open Competition4
Definitive Contract4

Hear when National Institute for Pharmaceutical Technology & Education Inc. wins an award and when a contract it holds is about to end.Follow it

Contracts ending soon

Contracts National Institute for Pharmaceutical Technology & Education Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.

Ending
3
Obligated so far
$634,642
Soonest
September 28, 2027

The 3 contracts, the office behind each one and the dates are in the workspace. See them

Competes with

Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Food and Drug Administration, by dollars.

University of ConnecticutStorrs, CT$11,942,361
The Medical Device Innovation ConsortiumArlington, VA$6,661,062
Rochester Institute of TechnologyRochester, NY$4,223,295
University of Massachusetts LowellLowell, MA$3,769,119
Beth Israel Deaconess Medical Center, Inc.Boston, MA$2,492,797
Integrated Behavioral Health, Inc.Costa Mesa, CA$2,344,536

Awards

Every award in the window, by dollars obligated.

ContractObligated
75F40126C00054Definitive Contract, July 14, 2026, Full and Open Competition, 1 offers$1,517,240
75F40126C00069Definitive Contract, September 15, 2026, Full and Open Competition, 1 offers$634,642
75F40122C00122Definitive Contract, August 16, 2024, Full and Open Competition, 1 offers$0
75F40122C00192Definitive Contract, June 11, 2025, Full and Open Competition, 165 offers$0
Places of performance
MinnesotaMaryland
Product and service codes
AJ12 General Science And Technology R&D Services; General Science And Technology; Applied ResearchAJ11 General Science And Technology R&D Services; General Science And Technology; Basic ResearchAN11 Health R&D Services; Health Care Services; Basic ResearchAN41 Health R&D Services; Health Care - Other; Basic Research
Transactions
9 across 4 awards